Skip navigation

Health and Life Science

Medical and technological innovation, as well as changes in public health and demographics, present new opportunities for growth, but also a need for prioritization. Oslo Economics has competence within:

  • Pharmaceuticals, device and market access
  • Biostatistics and research dissemination
  • Analysis of real world evidence (RWE)
  • Burden of disease and cost of illness (COI)
  • HR, personnel costs and labor market analyses
  • Analysis of sectors and ripple effects
  • Capital budgeting and concept selection for hospitals
  • Organizing and patient flow
  • Public-private cooperation
  • Innovation and the health industry
Contact us
Erik Magnus Sæther
Erik Magnus Sæther
Relevant articles